Citadel Advisors - THERAVANCE INC ownership

THERAVANCE INC's ticker is and the CUSIP is 88338T954. A total of 2 filers reported holding THERAVANCE INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of THERAVANCE INC
ValueSharesWeighting
Q4 2015$291,000
+646.2%
27,600
+411.1%
0.00%
Q3 2015$39,000
-45.8%
5,400
+35.0%
0.00%
Q2 2015$72,000
-77.2%
4,000
-80.1%
0.00%
Q1 2015$316,000
+6.8%
20,100
-3.8%
0.00%
Q4 2014$296,000
-61.4%
20,900
-53.5%
0.00%
-100.0%
Q3 2014$767,000
+239.4%
44,900
+490.8%
0.00%
Q2 2014$226,000
-81.6%
7,600
-80.9%
0.00%
-100.0%
Q1 2014$1,228,000
-27.8%
39,700
-16.8%
0.00%
-50.0%
Q4 2013$1,701,000
-3.7%
47,700
+10.4%
0.00%
-33.3%
Q3 2013$1,766,000
-22.8%
43,200
-27.3%
0.00%
-25.0%
Q2 2013$2,289,00059,4000.00%
Other shareholders

There were no reported owners of THERAVANCE INC in Q2 2015.

NameSharesValueWeighting ↓
View complete list of THERAVANCE INC shareholders